About TScan Therapeutics Inc
- Industry: Biotechnology
- Exchange: NASDAQ NMS - GLOBAL MARKET
- Country: US
- Website: https://www.tscan.com
Frequently Asked Questions
What is the 52-week range for TCRX?
The 52-week high is $2.57 and the 52-week low is $0.2902.
What is the P/E ratio for TCRX?
The P/E ratio data is currently unavailable.
What is the dividend yield for TCRX?
This company does not currently pay a dividend or the data is unavailable.
What is the Return on Equity (ROE)?
The trailing twelve months (TTM) Return on Equity is -108.72%.
What is the Net Profit Margin?
The Net Profit Margin (TTM) is -1655.35%.
What is the Price to Book (P/B) Ratio?
The annual Price to Book ratio stands at 0.46.
Analyst Recommendation Trends
Wall Street analyst consensus for TCRX over the last few months:
Latest TCRX News
Unusual volume stocks in Tuesday's session
Which stocks have an unusual volume on Tuesday?
HC Wainwright & Co. Downgrades TScan Therapeutics to Neutral, Lowers Price Target to $1
HC Wainwright & Co. analyst Andres Y. Maldonado downgrades TScan Therapeutics (NASDAQ:TCRX) from Buy to Neutral and lowers the price target from $7 to $1.
TScan Therapeutics, Inc. (TCRX) Discusses Strategic Refocus on In Vivo Cell Therapy for Solid Tumors and Pausing of Phase III Heme Study - Slideshow
2026-09-04. The following slide deck was published by TScan Therapeutics, Inc.
Ionis’ rare neurology drug approved; Pfizer inks an ADC deal
Zanvastro is now the first approved medicine for Alexander disease. Elsewhere, an immune system specialist posted positive results and a cell therapy developer turned to layoffs.
Related Stocks (Peers)
Recent Insider Transactions
| Date | Name | Shares Changed | Price | Value |
|---|---|---|---|---|
| 2026-10-01 | ZDRAVESKI ZORAN | +300,000 | - | - |
| 2026-10-01 | MacBeath Gavin | +1,000,000 | - | - |
| 2026-05-20 | Woods Keith | +67,000 | - | - |
| 2026-05-20 | Gruia Gabriela | +67,000 | - | - |
| 2026-05-20 | Klencke Barbara | +67,000 | - | - |
| 2026-05-20 | Nicholson Garry A | +67,000 | - | - |
| 2026-05-20 | Dorton Katina | +67,000 | - | - |
| 2026-05-20 | BAKER JULIAN | +67,000 | - | - |
| 2026-05-20 | BAKER JULIAN | +67,000 | - | - |
| 2026-01-20 | Dworak Leiden | +100,000 | - | - |
| 2026-01-20 | Louis Chrystal | +420,000 | - | - |
| 2026-01-20 | ZDRAVESKI ZORAN | +350,000 | - | - |
| 2026-01-20 | MacBeath Gavin | +1,165,000 | - | - |
| 2026-01-20 | Amello Jason | +350,000 | - | - |
| 2025-12-23 | Nichols Weston | +6,232 | $0.8989 | $5,602 |
| 2025-12-22 | Nichols Weston | +75,500 | $0.9 | $67,950 |
| 2025-12-19 | Nichols Weston | +80,069 | $0.8989 | $71,974 |